---
granola_id: 9abf83f9-c219-4a09-a60e-eb7c87e4079d
title: "Sathya <> Emre"
type: note
created: 2025-12-01T21:03:37.193Z
updated: 2025-12-01T21:30:31.488Z
attendees:
  - sathyahari9@gmail.com
---
### Sathya’s Background & Verse Experience

- Joined Verse around DME pivot from Jet Lenses (contact lens DTC business)
	- Timing: ~1 month after pivot decision
	- Double-dipped for first year before fully shutting down Jet Lenses
- 3 years total: started as early engineer, moved to product role
	- Worked on zero-to-one initiatives within DME space
	- Glucose monitoring regulatory roadmap and distributor strategy
	- Dual eligible special needs plans (D-SNP) case management
	- Initial enterprise sales strategy with Atlantic Health (Jersey)
- Left due to DME space limitations for broader healthcare cost reduction impact

### Current Role - Vivian Health Plan

- Just joined founding team with Tom and Shin (founders)
- Building health plan for level funded/self funded market
- Strong value proposition enabling 18-month conversations → 2 weeks with brokers
- Focus: owning total addressable market (TAM) on payer side
	- Key insight: need to be decision maker to influence patient behavior and drive down costs
	- Clear margins vs MA plans with heavy regulatory burden

### Healthcare Investment Themes Discussion

- Virtue VC overview: healthcare-only fund, $55M Fund 2, $500K-$3M checks
	- 75% lead rate across 28 companies
	- No pure therapeutic assets
- Secular trends of interest:
	- Women’s health intersection with orthopedics (women drive ~70% orthopedic revenue)
	- Personalized medicine via bioinformatics interpretation
	- Patient embeddings models for outcome prediction
	- Second-order impacts from tech/regulation creating new business models
- Level funded space experience through Right Wise portfolio company (pharmacy benefit carve-outs)

Chat with meeting transcript: https://notes.granola.ai/t/91c10bca-8014-45bf-b767-9013a824b1d7
